TWO · 6610.TWO
TWi Biotechnology, Inc.
NT$17.90-NT$0.10 (-0.56%)
TWi Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.71% below the high.
Loading market information…
TWO · 6808.TWO · TWD
Stock price, dividends
Quote as of Oct 30, 2026, 06:46 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
3D Global Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.66% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
3D Global Biotech Inc.’s forward annual dividend is NT$0.13 per share, paid annual. The forward yield is 0.46% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE COMPANY BEHIND THE TICKER
Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in the development of advanced medical materials designed for human body reconstruction. The company leverages sophisticated cell culture systems, cutting-edge 3D printing technology, and proprietary bio-inks hydrogel to create personalized, patient-specific cell-based medical products. Beyond product manufacturing, 3DGBI is dedicated to building platforms for human tissue and organ regeneration, engineering customized medical equipment, and undertaking significant professional research. Its extensive product range includes artificial bone substitutes, skull fixation systems, biological dressings, bio-inks, and bioprinting machinery. They also offer specialized solutions for orthopedic, dental, cranial, and scalp reconstruction. The company serves a broad spectrum of clients, including medical centers, research institutions, businesses, and distributors. 3DGBI actively fosters an interdisciplinary alliance, bringing together expertise from industry, government, academia, research, and medicine. It was established in 2014.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$17.90-NT$0.10 (-0.56%)
TWi Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.71% below the high.
NT$27.95-NT$0.45 (-1.58%)
BRIM Biotechnology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.34% below the high.
NT$76.80+NT$0.30 (+0.39%)
SYN-TECH Chem. & Pharm. Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.42% below the high.
NT$45.75+NT$0.55 (+1.22%)
Sagittarius Life Science Corp’s quoted price sits in the lower half of its reported 52-week range, 31.72% below the high.
NT$60.40-NT$2.10 (-3.36%)
Shine-On BioMedical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.05% below the high.
NT$29.00-NT$0.75 (-2.52%)
Apex Biotechnology Corp.’s quoted price sits in the lower half of its reported 52-week range, 15.45% below the high.
NT$32.00-NT$0.60 (-1.84%)
Energenesis Biomedical CO.,LTD.’s quoted price sits in the lower half of its reported 52-week range, 46.4% below the high.
NT$83.40-NT$2.40 (-2.8%)
Syngen Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.85% below the high.
